Welcome to ESMYA.COM,
an online portal for healthcare professionals managing uterine fibroids.
Esmya.com is an international information resource intended for international healthcare professionals with an interest in Esmya® (ulipristal acetate 5mg) and the pre-operative treatment of symptomatic uterine fibroids.
Please select from any of the portals below, as relevant to your needs.
Uterine fibroids is a benign disease with significant negative impact on a woman’s life. It affects over 40 million women of reproductive age (20% to 40%).
For U.S. audiences, please click here
Please visit this public portal if you are a patient outside the U.S
Esmya.com is intended for healthcare professionals only.
If you are a patient, you should visit fibroidsconnect.com, an online resource for patients outside the U.S, designed to help you learn more about uterine fibroids, its symptoms, treatment options and gives information about your nearest specialist centre.
Patients should contact their treating physicians for any questions related to the treatment of uterine fibroids.
Continue to public portal
This website is intended for healthcare professionals only
|Efficacy and safety data of Esmya® (ulipristal acetate 5mg)|
|Clinical reprints, slide kits, videos, podcasts, eLearning programs, and more|
|Browse the catalogue of educational materials and email relevant materials directly to your patient.|
|By clicking on the continue button, you confirm you are a registered healthcare professional.|
If you are a member of the press, a blogger or an industry observer visit the Gedeon Richter Press Room to get the latest press releases.
Continue to Press Room
For regulatory reasons, please choose your country of residence to access available information about Esmya® (ulipristal acetate 5mg).
If your country is not listed, please visit our international website.